As the new interim vice dean for research at the University of Illinois College of Medicine, veteran Indian American health administrator, Dr. Jerry Krishnan, provides leadership and strategic direction across all campuses.
Stepping into his new role last month, Krishnan oversees a massive scientific network, including key initiatives like the Center for Cardiovascular Research and AIHealthcare4All.
Krishnan has taken charge of the college’s basic, clinical, and translational research enterprises across its Chicago, Peoria, Rockford, and Urbana campuses at a time of significant momentum for the University of Illinois System, which recently reported a research and development portfolio surpassing $1 billion in annual expenditures.
Krishnan’s journey into the upper echelons of American medical leadership is rooted in Mumbai, India. Born in the coastal metropolis, he often reflects the rigorous educational discipline characteristic of his heritage. He moved to the United States to pursue his medical training, eventually earning his medical degree with honors from Baylor College of Medicine.
He later completed his residency and fellowship at the prestigious Johns Hopkins Hospital and earned a PhD in clinical investigation from the Johns Hopkins Bloomberg School of Public Health.
Read: Indian American educationist Lakshmi N. Reddi named Nevada university provost
A practicing pulmonologist, Krishnan has built a career centered on “bench-to-bedside” science. His work is primarily focused on care delivery for chronic lung diseases, asthma, and more recently, the long-term effects of Covid-19.
Before his elevation, Krishnan served as the associate vice chancellor for population health sciences at UIC, where he bridged the gap between complex data and community health outcomes.
Beyond his administrative duties, Krishnan is recognized for humanizing medical research. He has been a vocal proponent of including marginalized communities in clinical trials, ensuring that scientific advancements are equitable and accessible.
His previous leadership as the chair of the FDA’s Pulmonary-Allergy Drugs Advisory Committee underscores his influence on national health policy.
As interim vice dean, Krishnan is tasked with mentoring faculty and optimizing research resources, including laboratory space and multi-million dollar budgets. While the “interim” designation implies a transition, the Mumbai-born scholar is already deeply embedded in the college’s mission to integrate high-level discovery with the daily clinical needs of the UI Health system.